Practical Application of Immuno-Oncology in RCC: Expert Discussion of Second-line Therapy and Beyond

In this episode, an expert medical oncology panel, led by Elizabeth R. Plimack, MD, with Brian A. Costello, MD, and Martin H. Voss, MD, discusses current best practices for the second-line treatment and beyond of patients with metastatic renal cell carcinoma (RCC). Topics include:

•           Treatment sequencing with IO and TKI therapies

•           Optimizing dose for patients with preexisting toxicities

•           Considerations for local control of metastatic sites 

•           Ongoing clinical trials

Presenters:

Elizabeth R. Plimack, MD, MS
Chief, Division of Genitourinary Medical Oncology 
Director, Genitourinary Clinical Research 
Professor, Department of Hematology/Oncology 
Fox Chase Cancer Center 
Temple Health 
Philadelphia, Pennsylvania

Brian A. Costello, MD
Associate Professor of Oncology and Urology
Division of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Martin H. Voss, MD
Clinical Director, Genitourinary Medical Oncology Service
Memorial Sloan Kettering Cancer Center
Assistant Professor 
Weill Cornell Medical College
New York, New York

Content based on an online CME program supported by an educational grant from Eisai, Exelixis, and Pfizer and EMD Serono.

Link to full program:
https://bit.ly/32IS9gx

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.